Leukemia, Myeloid, Accelerated Phase - 12 Studies Found

Completed : Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
: Chronic Myelogenous Leukemia
: 2005-01-12
: Drug: Dasatinib Tablets, Oral, 70 mg, twice daily, until disease progression or intolerable toxicity, sw
Completed : STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia
: Leukemia
: 2000-07-05
: Drug: imatinib mesylate
Completed : Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia
: Leukemia
: 2005-05-03
:
  • Biological: recombinant interferon alfa
  • Bi
Terminated : Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia
: Chronic Myeloid Leukemia
: 2009-05-06
: Drug: Dasatinib (Sprycel) 100mg of Dasatinib will be administered as tablets, by mouth, once a day (or t
Withdrawn : Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia
: Leukemia, Myeloid, Chronic
: 2008-08-07
: Biological: Ipilimumab IV Solution, IV, 10 mg/kg, (if dose reduction necessary at 3 mg/kg), Every three
Recruiting : A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)
: Chronic Myeloid Leukemia
: 2014-02-28
: Drug: Omacetaxine mepesuccinate 3.5 mg omacetaxine mepesuccinate and 10 mg mannitol; The first dose of t
Terminated : Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Chronic Myelogen
    : 2011-08-30
    :
    • Drug: dasatinib Given PO
Completed : Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Blastic Phase Ch
    : 2003-02-05
    :
    • Drug: imatinib mesylate Given

Terminated : Temsirolimus and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Blastic Phase Ch
    : 2005-01-07
    :
    • Drug: imatinib mesylate Given

Recruiting : Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia
:
  • Chronic Phase Chronic Myeloid Leukemia
  • Accelerated Phase Chronic Myelo
    : 2013-07-28
    :
    • Drug: Nilotinib Nilotinib dose
Next >>>